期刊文献+

伊曲茶碱的合成研究

Synthesis of istradefylline
原文传递
导出
摘要 目的优化抗帕金森病药伊曲茶碱1的合成工艺以适用于工业化生产。方法将碳酸二甲酯和乙胺经缩合、环合、亚硝化、还原得1,3-二乙基-5,6-二氨基尿嘧啶(6),化合物6与(E)-3,4-二甲氧基苯丙烯酸(8)进行缩合、闭环、甲基化反应制得伊曲茶碱1。化合物8可由3,4-二甲氧基苯甲醛(7)和丙二酸经Knoevenagel缩合反应制得。中间体及目标化合物经过MS和~1H-NMR确证。结果与结论对各关键工艺质量控制点的工艺进行优化,使合成总收率达26.2%,产品纯度为99.76%。改进后的工艺条件温和,操作简便,无需柱层析,适合工业化生产。 Objective To optimize the synthesis process of istradefylline 1 for industrial production.Methods Istradefylline was synthesized from dimethyl carbonate and ethylamine through a series reactions including condensation,cyclization,nitrosation,and reduction to produce 1,3-diethyl-5,6-diaminouraeil(6),which was subjected to amidation with(E)-3,4-dimethoxycinnamic acid(8).followed by cyclization and methylation reaction.Compound 8 was prepared from veratraldehyde and propanedioic acid by Knoevenagel condensation.The structures of intermediate and target compounds were confirmed by MS and 1 H-NMR.Results and Conclusion The quality control points of each key process were optimized so that the total yield was 26.2%and the purity of the product was 99.76%.This improved synthesis method has some advantages,such as mild reaction conditions,simple operation,and applicability to industrial production.
作者 齐军阳 张珩 曹爽 杨艺虹 别旋 王莹 QI Jun-yang ZHANG Heng CAO Shuang YANG Yi-hong BIE Xuan WANG Ying(School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan 430073, Chin)
出处 《军事医学》 CAS CSCD 北大核心 2017年第2期114-117,共4页 Military Medical Sciences
基金 武汉工程大学第七届研究生教育创新基金项目(CX2015072)
关键词 伊曲茶碱 抗帕金森药 合成 istradefylline antiparkinsonism agent synthesis
  • 相关文献

参考文献4

二级参考文献17

  • 1罗京京.抗帕金森病药Istradefylline[J].药学进展,2004,28(12):574-575. 被引量:2
  • 2Jiang YM Mo XA Du FQ Fu X Zhu XY Gao HY Xie JL Liao FL Pira E Zheng W.Effective treatment of manganese-induced occupational parkinsonism with p-aminosalicylic acid: a case of 17-year follow-up study.[J].中国生物学文摘,2006,20(8):8-8. 被引量:24
  • 3Suzuki F,Shimada J,Koike N,et al.Therapeutic agent for Parkinson's disease:US,5484920[P].1996-01-16.
  • 4Hockemeyer J,Burbiel JC,Müller CE.Multigram-scale syntheses,stability,and photoreactions of A_(2a),adenosine receptor antagonists with 8-styrylxanthine structure:Potential drugs for Parkinson's disease[J].J Org Chem,2004,69(10):3308-3318.
  • 5Stabile RG,Dicks AP.Two-step semi-microscale preparation of a cinnamate ester sunscreen analog[J].J Chem Educ,2004,81(10):1488-1491.
  • 6Miwa K,Ito K,Kato N,et al.Synthesis of uracil derivation:JP,1997040652[P].1997-02-10.
  • 7Papesch V,Schroeder EF.Synthesis of 1-mono-and 1,3-di-substituted-6-aminouracils diuretic activity[J].J Org Chem,1951,42(14):1879-1890.
  • 8Blicke FF,Godt HC.Reactions of 1,3-dimethyl-5,6-diaminouracil[J].J Am Chem Soc,1954,76(10):2798-2800.
  • 9Speer JH,Raymond AL.Some alkyl homologs of theophylline[J].J Am Chem Soc,1953,75(1):114-115.
  • 10Fumio S. Therapeutic agents for parkinson's disease: EP, 0590919 [P]. 1994-04-06.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部